Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NPC1L1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NPC1L1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
HMGCR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
HMGCR target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
ACLY Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
ACLY target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
SCD1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
SCD1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
FASN Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
FASN target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
ACACA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
ACACA target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
DGAT2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
DGAT2 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
DGAT1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
DGAT1 target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
PPARG Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PPARG target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
PPARA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PPARA target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
CETP Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
CETP target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.
Latest Hotspot
8 min read
LPA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
LPA target evaluation report generated from PatSnap Life Sciences MCP workflows, combining biology, validation evidence, clinical competition, IP context, and R&D strategy.